Tirzepatide Dosage Calculator

This tirzepatide dosage calculator estimates syringe units, concentration, vial yield, and how long a vial will last based on vial size, water volume, and amount per dose

Common tirzepatide parameters are pre-selected for faster calculation.

Reconstitution guide

Use our Peptide Calculator below to calculate accurate dosages foradministering peptides using a syringe.

STEP 1

Set your dose

Choose your intended dose in micrograms (mcg): This is the amount of peptide you plan to inject each time.

STEP 2

Enter your peptide strength

Enter the peptide strength in your vial. You can select a common amount, such as 1mg, 5mg, 10mg, or 15mg. If your amount isn’t listed, you can manually type in the exact amount.

STEP 3

Add your water volume

The volume of water you add affects the concentration of the peptide solution. Enter the amount of water in milliliters (mL).

Tirzepatide Dosage: What the research says

This information is based on preclinical and clinical research studies. Tirzepatide Calculator is not FDA-approved for human use. This content is for research and informational purposes only

Common Research Doses

Low (2.5mg): The universal initiation dosage documented in clinical literature. Research protocols require starting at this threshold for 4 weeks to assess baseline gastrointestinal tolerability and initiate systemic metabolic adaptation before any upward titration occurs.¹
Mid (5.0mg): The first established maintenance dosage. In experimental models, reaching and sustaining this dosage correlates with significant shifts in glycemic control, resting energy expenditure, and lipid metabolism.²
High (10.0mg): A high-tier maintenance threshold evaluated in long-term efficacy trials. Studies demonstrated profound shifts in systemic fat mass clearance and HbA1c reduction at 10.0mg and up to 15.0mg, though researchers universally mandate a strict, step-wise titration schedule (increasing by 2.5mg every 4 weeks) to mitigate autonomic stress and gastrointestinal adverse events.¹

Frequency of Administration

In experimental protocols, tirzepatide is administered once weekly. Given its extended systemic half-life (approximately 5 days) and potent dual-receptor agonism, weekly intervals provide a stable pharmacokinetic profile without causing overlapping receptor saturation or acute hypoglycemic events.²

Route of Administration

The standard and thoroughly documented route in clinical literature is Subcutaneous (SubQ) injection, typically in the abodmen. Subcutaneous delivery ensures steady systemic absorption and distribution to target receptors across the pancreas, central nervous system, and gastrointestinal tract.¹

Study Duration

Tirzepatide research generally follows longitudinal timelines to safely escalate the dosage and track long-term metabolic remodeling:

Acute / Titration Phase: 4 to 20 weeks to safely titrate the compound from the 2.5mg baseline up to the target maintenance dose, allowing researchers to observe progressive gastrointestinal adaptation.
Longitudinal / Efficacy Phase: 40 to 72+ weeks. Extensive Phase 3 trials administered tirzepatide continuously for 72 weeks to observe sustained weight loss, plateau effects, and prolonged metabolic safety markers.¹

Evidence Limitations

While commercial pharmaceutical formulations of tirzepatide have received FDA approval for the management of type 2 diabetes and obesity, the research-grade peptide data provided here is strictly for educational context. All Honest Peptide compounds are restricted strictly to Research Use Only (RUO) and are not for human consumption or therapeutic use. For catalog navigation and laboratory procurement, Tirzepatide is designated within our catalog under the compliant nomenclature GLP-2 TZ.

Scientific References

Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021;385(6):503-515. https://pubmed.ncbi.nlm.nih.gov/34170647/

Shop peptides

-30%

Semax 10mg

$70.00$49.00